Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

PubMed  Google Scholar 

Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70:145–64.

Article  PubMed  Google Scholar 

Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369:1106–14.

Article  CAS  PubMed  Google Scholar 

Tao S, Haug U, Kuhn K, et al. Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening. Br J Cancer. 2012;106:1424–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie YH, Gao QY, Cai GX, et al. Fecal clostridium symbiosum for noninvasive detection of early and advanced colorectal cancer: test and validation studies. EBioMedicine. 2017;25:32–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Niedermaier T, Tikk K, Gies A, et al. Sensitivity of fecal immunochemical test for colorectal cancer detection differs according to stage and location. Clin Gastroenterol Hepatol. 2020;18(2920–8):e6.

Google Scholar 

Thomas DS, Fourkala EO, Apostolidou S, et al. Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples. Br J Cancer. 2015;113:268–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao M, Li M, Yang Y, et al. A comprehensive analysis and annotation of human normal urinary proteome. Sci Rep. 2017;7:3024.

Article  PubMed  PubMed Central  Google Scholar 

Okuda Y, Shimura T, Iwasaki H, et al. Urinary microRNA biomarkers for detecting the presence of esophageal cancer. Sci Rep. 2021;11:8508.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shimura T, Dagher A, Sachdev M, et al. Urinary ADAM12 and MMP-9/NGAL complex detect the presence of gastric cancer. Cancer Prev Res (Phila). 2015;8:240–8.

Article  CAS  PubMed  Google Scholar 

Shimura T, Ebi M, Yamada T, et al. Urinary kallikrein 10 predicts the incurability of gastric cancer. Oncotarget. 2017;8:29247–57.

Article  PubMed  PubMed Central  Google Scholar 

Iwasaki H, Shimura T, Yamada T, et al. A novel urinary microRNA biomarker panel for detecting gastric cancer. J Gastroenterol. 2019;54:1061–9.

Article  PubMed  Google Scholar 

Shimura T, Dayde D, Wang H, et al. Novel urinary protein biomarker panel for early diagnosis of gastric cancer. Br J Cancer. 2020;123:1656–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iwasaki H, Shimura T, Kitagawa M, et al. A novel urinary miRNA biomarker for early detection of colorectal cancer. Cancers (Basel). 2022;14:461.

Article  CAS  PubMed  Google Scholar 

Shimura T, Iwasaki H, Kitagawa M, et al. Urinary cysteine-rich protein 61 and trefoil factor 3 as diagnostic biomarkers for colorectal cancer. Transl Oncol. 2019;12:539–44.

Article  PubMed  PubMed Central  Google Scholar 

McShane LM, Altman DG, Sauerbrei W, et al. Reporting recommendations for tumor marker prognostic studies. J Clin Oncol. 2005;23:9067–72.

Article  PubMed  Google Scholar 

Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007;18:805–35.

Article  PubMed  Google Scholar 

Sobin LH, Gospodarowicz MK, Wittekind C, et al. TNM classification of malignant tumours. 7th ed. Chichester: Wiley-Blackwell; 2009.

Google Scholar 

Rappsilber J, Ishihama Y, Mann M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem. 2003;75:663–70.

Article  CAS  PubMed  Google Scholar 

Xin G, Wang M, Jiao LL, et al. Protein-to-creatinine ratio in spot urine samples as a predictor of quantitation of proteinuria. Clin Chim Acta. 2004;350:35–9.

Article  CAS  PubMed  Google Scholar 

Ward DG, Nyangoma S, Joy H, et al. Proteomic profiling of urine for the detection of colon cancer. Proteome Sci. 2008;6:19.

Article  PubMed  PubMed Central  Google Scholar 

Sun Y, Guo Z, Liu X, et al. Noninvasive urinary protein signatures associated with colorectal cancer diagnosis and metastasis. Nat Commun. 2022;13:2757.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeng C, Qi G, Shen Y, et al. DPEP1 promotes drug resistance in colon cancer cells by forming a positive feedback loop with ASCL2. Cancer Med. 2023;12:412–24.

Article  CAS  PubMed  Google Scholar 

Zhang G, Schetter A, He P, et al. DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma. PLoS ONE. 2012;7:e31507.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McIver CM, Lloyd JM, Hewett PJ, et al. Dipeptidase 1: a candidate tumor-specific molecular marker in colorectal carcinoma. Cancer Lett. 2004;209:67–74.

Article  CAS  PubMed  Google Scholar 

Park SY, Lee SJ, Cho HJ, et al. Dehydropeptidase 1 promotes metastasis through regulation of E-cadherin expression in colon cancer. Oncotarget. 2016;7:9501–12.

Article  PubMed  PubMed Central  Google Scholar 

Yajima S, Ishii M, Matsushita H, et al. Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer. Int J Oncol. 2007;31:1029–37.

CAS  PubMed  Google Scholar 

Liu Q, Deng J, Yang C, et al. DPEP1 promotes the proliferation of colon cancer cells via the DPEP1/MYC feedback loop regulation. Biochem Biophys Res Commun. 2020;532:520–7.

Article  CAS  PubMed  Google Scholar 

Yusufu A, Shayimu P, Tuerdi R, et al. TFF3 and TFF1 expression levels are elevated in colorectal cancer and promote the malignant behavior of colon cancer by activating the EMT process. Int J Oncol. 2019;55:789–804.

CAS  PubMed  PubMed Central  Google Scholar 

Xiao P, Ling H, Lan G, et al. Trefoil factors: Gastrointestinal-specific proteins associated with gastric cancer. Clin Chim Acta. 2015;450:127–34.

Article  CAS  PubMed  Google Scholar 

Rodrigues S, Rodrigue CM, Attoub S, et al. Induction of the adenoma-carcinoma progression and Cdc25A-B phosphatases by the trefoil factor TFF1 in human colon epithelial cells. Oncogene. 2006;25:6628–36.

Article  CAS  PubMed  Google Scholar 

Vocka M, Langer D, Petrtyl J, et al. Trefoil factor family (TFF) proteins as potential serum biomarkers in patients with metastatic colorectal cancer. Neoplasma. 2015;62:470–7.

Article  CAS  PubMed  Google Scholar 

Tokuhara T, Hattori N, Ishida H, et al. Clinical significance of aminopeptidase N in non-small cell lung cancer. Clin Cancer Res. 2006;12:3971–8.

Article  CAS  PubMed  Google Scholar 

Sanz B, Perez I, Beitia M, et al. Aminopeptidase N activity predicts 5-year survival in colorectal cancer patients. J Investig Med. 2015;63:740–6.

Article  CAS  PubMed  Google Scholar 

Wiese AH, Auer J, Lassmann S, et al. Identification of gene signatures for invasive colorectal tumor cells. Cancer Detect Prev. 2007;31:282–95.

Article  CAS  PubMed  Google Scholar 

Lu X, Pan J, Li S, et al. Establishment of a predictive genetic model for estimating chemotherapy sensitivity of colorectal cancer with synchronous liver metastasis. Cancer Biother Radiopharm. 2013;28:552–8.

CAS  PubMed  PubMed Central  Google Scholar 

Endo K, Kohnoe S, Tsujita E, et al. Galectin-3 expression is a potent prognostic marker in colorectal cancer. Anticancer Res. 2005;25:3117–21.

CAS  PubMed  Google Scholar 

Krijgsman D, Roelands J, Andersen MN, et al. Expression of NK cell receptor ligands in primary colorectal cancer tissue in relation to the phenotype of circulating NK- and NKT cells, and clinical outcome. Mol Immunol. 2020;128:205–18.

Article  CAS  PubMed  Google Scholar 

Rasmussen L, Nielsen HJ, Christensen IJ. Early detection and recurrence of colorectal adenomas by combination of eight cancer-associated biomarkers in plasma. Clin Exp Gastroenterol. 2020;13:273–84.